Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

January-February, 2025
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Regulation

Cipla receives EIR for Indore plant

Cipla receives EIR for Indore plant

Cipla announced the closure of the US FDA product-specific Pre-Approval Inspection.

As per the regulatory filing, following the product-specific Pre-Approval Inspection (PAI) by the United States Food and Drug Administration (USFDA) at the Indore plant from June 27, 2022, to July 01, 2022, the company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection.

 
Read more on:
Cipla EIR PAI US FDA
More news about: regulation | Published by Sudeep Soparkar | September - 23 - 2022 | 635

Last news about this category

MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation
Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards
Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group
Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
Gland Pharma Receives EIR From USFDA For Dundigal Facility Gland Pharma Receives EIR From USFDA For Dundigal Facility
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
Glenmark Pharma settles drug pricing case with US Department of Justice Glenmark Pharma settles drug pricing case with US Department of Justice
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy